Citadel Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-35,816
| Closed | -$537K | – | 4456 |
|
|
2016
Q2 | $537K | Buy |
+35,816
| New | +$537K | ﹤0.01% | 2195 |
|
|
2016
Q1 | – | Sell |
-23,799
| Closed | -$379K | – | 4409 |
|
|
2015
Q4 | $379K | Buy |
+23,799
| New | +$379K | ﹤0.01% | 2569 |
|
|
2015
Q3 | – | Sell |
-77,385
| Closed | -$1.88M | – | 4523 |
|
|
2015
Q2 | $1.88M | Sell |
77,385
-95,106
| -55% | -$2.31M | ﹤0.01% | 1765 |
|
|
2015
Q1 | $4.01M | Buy |
172,491
+55,614
| +48% | +$1.29M | ﹤0.01% | 1391 |
|
|
2014
Q4 | $2.94M | Buy |
+116,877
| New | +$2.94M | ﹤0.01% | 1455 |
|
|
2014
Q3 | – | Sell |
-21,752
| Closed | -$562K | – | 3931 |
|
|
2014
Q2 | $562K | Sell |
21,752
-520,506
| -96% | -$13.4M | ﹤0.01% | 2209 |
|
|
2014
Q1 | $12.7M | Buy |
+542,258
| New | +$12.7M | 0.01% | 742 |
|
|
2013
Q4 | – | Sell |
-21,697
| Closed | -$443K | – | 3328 |
|
|
2013
Q3 | $443K | Buy |
21,697
+2,778
| +15% | +$56.7K | ﹤0.01% | 1946 |
|
|
2013
Q2 | $397K | Buy |
+18,919
| New | +$397K | ﹤0.01% | 2019 |
|